Hervolution Therapeutics Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $7.69M

  • Investors
  • 10

Hervolution Therapeutics General Information

Description

Operator of a biotechnology company intended to treat cancer by targeting tumor viruses within the human genome. The company offers broad and curative cancer therapy in combination with immune checkpoint inhibitors, enabling medical researchers to easily find treatment for cancer using adaptive immune therapy.

Contact Information

Formerly Known As
InProTher
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Fuglebakken
  • Nordre Fasanvej 215
  • 2000 Frederiksberg
  • Denmark
+45 23
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Fuglebakken
  • Nordre Fasanvej 215
  • 2000 Frederiksberg
  • Denmark
+45 23

Hervolution Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hervolution Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series A) 19-Dec-2024 $7.69M Completed Generating Revenue
9. Later Stage VC (Series A) 24-May-2023 Cancelled Generating Revenue
8. Seed Round 06-Mar-2023 Completed Generating Revenue
7. Grant 16-Jun-2021 Completed Generating Revenue
6. Early Stage VC Completed Generating Revenue
5. Angel (individual) 15-Feb-2021 Completed Generating Revenue
4. Grant 30-Oct-2020 Completed Generating Revenue
3. Corporate 05-Feb-2020 Completed Generating Revenue
2. Corporate 15-Feb-2019 $1.52M $1.58M Completed Generating Revenue
1. Accelerator/Incubator 21-Nov-2018 $53.4K $53.4K Completed Generating Revenue
To view Hervolution Therapeutics’s complete valuation and funding history, request access »

Hervolution Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
To view Hervolution Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Hervolution Therapeutics Patents

Hervolution Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026139129-A1 Chimeric vlp forming polypeptides comprising beta-retroviral gag Pending 23-Dec-2024
WO-2026139580-A1 Chimeric vlp forming polypeptides comprising beta-retroviral gag Pending 23-Dec-2024
WO-2025153852-A1 Production of viral vectors Pending 17-Jan-2024
AU-2024306288-A1 Chimeric vlp forming polypeptides comprising beta-retroviral gag Pending 27-Jun-2023
EP-4735030-A1 Chimeric vlp forming polypeptides comprising beta-retroviral gag Pending 27-Jun-2023 C07K14/005
To view Hervolution Therapeutics’s complete patent history, request access »

Hervolution Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hervolution Therapeutics Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Serum Institute of India PE-Backed Company Minority
European Innovation Council Accelerator/Incubator Minority
Horizon Europe Not-For-Profit Venture Capital
Angel (individual) Minority
Angel (individual) Minority
You’re viewing 5 of 10 investors. Get the full list »

Hervolution Therapeutics FAQs

  • When was Hervolution Therapeutics founded?

    Hervolution Therapeutics was founded in 2011.

  • Where is Hervolution Therapeutics headquartered?

    Hervolution Therapeutics is headquartered in Frederiksberg, Denmark.

  • What is the size of Hervolution Therapeutics?

    Hervolution Therapeutics has 18 total employees.

  • What industry is Hervolution Therapeutics in?

    Hervolution Therapeutics’s primary industry is Drug Discovery.

  • Is Hervolution Therapeutics a private or public company?

    Hervolution Therapeutics is a Private company.

  • What is the current valuation of Hervolution Therapeutics?

    The current valuation of Hervolution Therapeutics is .

  • What is Hervolution Therapeutics’s current revenue?

    The current revenue for Hervolution Therapeutics is .

  • How much funding has Hervolution Therapeutics raised over time?

    Hervolution Therapeutics has raised $15.7M.

  • Who are Hervolution Therapeutics’s investors?

    Serum Institute of India, European Innovation Council, Horizon Europe, , and are 5 of 10 investors who have invested in Hervolution Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process